홈
마켓
차트 & 아이디어
Algo
뉴스
Store
브로커
다운로드
경제 달력
트레이딩 시그널
웹터미널
Heatmap
검색
/
타입: @user, $symbol
검색
로그인
계정을 생성하십시오
한국어
English
Русский
中文
Español
Português
日本語
Deutsch
Français
Italiano
Türkçe
ALXO
#3604
ALX Oncology Holdings Inc. Common Stock
1.6
8
USD
+3.70%
부문:
헬스케어
베이스:
USD
수익 통화:
USD
일일 변동 비율
년간 변동
일일 변동
+3.70%
월간 변동
-16.00%
6달 변화
+1.20%
년간 변동율
+205.45%
이전 종가
1.6
2
Open
1.6
8
Bid
Ask
Low
1.6
8
High
1.6
8
양
27
마켓
주식
헬스케어
ALXO
Open full chart
Financials
Overview
성명
Statistics
Quarterly
Annual
Value
Q4, 24
Q1, 25
Q2, 25
Q3, 25
Q4, 25
TTM
Key stats
Total common shares outstanding
53.38 M
53.44 M
53.55 M
54.22 M
131.61 M
—
Valuation ratios
Enterprise value
82.45 M
23.64 M
13.97 M
86.83 M
143.05 M
267.49 M
Price to earnings ratio
-0.65
-0.25
-0.19
-0.91
-0.59
-1.95
Price to sales ratio
—
—
—
—
—
—
Price to cash flow ratio
-0.71
-0.3
-0.21
-1
-0.72
-2.23
Price to book ratio
0.77
0.07
0.05
0.31
2.33
2.77
EBITDA 비율에 대한 기업 가치
—
—
—
—
—
—
Profitability ratios
Return on assets %
-0.2
-0.25
-0.27
-0.27
-0.39
-1.18
Return on equity %
-0.26
-0.35
-0.4
-0.49
-0.88
-2.12
Return on invested capital %
-366.79
—
—
—
-345.01
—
Gross margin %
—
—
—
—
—
—
Operating margin %
—
—
—
—
—
—
EBITDA margin %
—
—
—
—
—
—
Net margin %
—
—
—
—
—
—
Liquidity ratios
Quick ratio
—
—
—
—
—
—
Current ratio
7.26
5.47
4.52
2.4
2.07
14.46
Inventory turnover
—
—
—
—
—
—
Asset turnover
—
—
—
—
—
—
Solvency ratios
Debt to assets ratio
0.07
0.09
0.12
0.13
0.18
0.52
Debt to equity ratio
0.1
0.12
0.17
0.25
0.41
0.95
Long term debt to total assets ratio
0.06
0.07
0.07
0.07
0.08
0.29
Long term debt to total equity ratio
0.08
0.09
0.11
0.13
0.17
0.5
Per share metrics
Operating cash flow per share
-0.61
-0.46
-0.44
-0.32
-0.35
-1.57
EBIT per share
—
—
—
—
—
—
EBITDA per share
—
—
—
—
—
—
Total debt per share
0.21
0.21
0.21
0.21
0.2
0.82
Cash per share
2.45
1.83
1.48
1.13
0.83
5.28
Net current asset value per share
2.58
1.92
1.6
1.24
0.95
5.7
Tangible book value per share
2.18
1.65
1.21
0.84
0.48
4.18
Working capital per share
2.22
1.57
1.24
0.72
0.49
4.02
Book value per share
2.18
1.65
1.21
0.84
0.48
4.18
뉴스
ALDX Crashes 71% as FDA Issues Third CRL for Dry Eye Disease Drug NDA
CTMX Stock Rallies on Strong Phase I Colorectal Cancer Study Data
IBRX Stock Jumps on Progress in NK Cell Therapy Production
JNJ's Bladder Cancer Therapy Meets Key Goal in Early-Stage Study
RARE's DTX301 Meets First Key Goal in Phase III OTC Deficiency Study
RLMD Stock Surges 42% in a Week: Here's What You Should Know
GSK Out-Licenses Rights for Rare Liver Disease Drug to Alfasigma
EDIT Stock Up on Narrower-Than-Expected Q4 Loss, Revenues Rise Y/Y
Roche's Giredestrant Misses Key Goal in First-Line Breast Cancer Study
LRMR Stock on the Move: What Sparked the 55% Jump in the Past Month?
QURE Stock Crashes 32% in a Week: Here's What You Should Know
Mirum Completes Enrollment & Screening in Liver Disease Studies